Kiniksa Pharmaceuticals Ltd (KNSA) Insider Trading
- $71,248,379.44
- $50,448,468.58
- Sept. 15, 2025
- Eben Tessari
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Aug. 27, 2024 | COO | 17,500 | $26.91 | Sell | $470,925.00 | |
| July 23, 2024 | CFO | 24,248 | $24.79 | Sell | $601,107.92 | |
| July 23, 2024 | Insider | 22,000 | $26.32 | Sell | $579,040.00 | |
| July 23, 2024 | CEO | 136,124 | $25.65 | Sell | $3,491,580.60 | |
| March 6, 2024 | CEO | 5,582 | $21.00 | Sell | $117,222.00 | |
| March 4, 2024 | CEO | 12,742 | $21.49 | Sell | $273,825.58 | |
| March 1, 2024 | CAO | 9,659 | $21.45 | Sell | $207,185.55 | |
| Feb. 28, 2024 | CAO | 5,126 | $21.79 | Sell | $111,695.54 | |
| Jan. 3, 2024 | CFO | 12,000 | $20.00 | Sell | $240,000.00 | |
| Jan. 2, 2024 | CAO | 16,670 | $19.17 | Sell | $319,563.90 | |
| Dec. 19, 2023 | CAO | 9,316 | $19.13 | Sell | $178,215.08 | |
| Dec. 7, 2023 | Insider | 28,600 | $17.65 | Sell | $504,790.00 | |
| Sept. 5, 2023 | Insider | 400 | $17.53 | Sell | $7,012.00 | |
| July 25, 2023 | Insider | 29,000 | $19.14 | Sell | $555,060.00 | |
| Nov. 29, 2022 | Director | 21,959 | $16.15 | Sell | $354,637.85 | |
| Feb. 9, 2021 | CEO | 20,401 | $23.04 | Sell | $470,039.04 | |
| Feb. 3, 2021 | EVP | 2,477 | $22.09 | Sell | $54,716.93 | |
| Oct. 12, 2020 | CEO | 150,700 | $21.02 | Sell | $3,167,714.00 | |
| Oct. 9, 2020 | CEO | 872 | $21.00 | Sell | $18,312.00 | |
| July 1, 2020 | EVP | 29,589 | $25.37 | Sell | $750,672.93 | |
| June 10, 2020 | EVP | 13,752 | $25.07 | Sell | $344,762.64 | |
| April 20, 2020 | EVP | 47,423 | $19.06 | Sell | $903,882.38 | |
| March 6, 2020 | CEO | 33,115 | $20.00 | Sell | $662,300.00 | |
| Feb. 19, 2020 | SVP | 22,477 | $18.27 | Sell | $410,654.79 | |
| Feb. 14, 2020 | SVP | 1,039 | $18.33 | Sell | $19,044.87 | |
| Feb. 14, 2020 | EVP | 59 | $18.58 | Sell | $1,096.22 | |
| May 29, 2018 | Director | 3,000,000 | $18.00 | Buy | $54,000,000.00 | |
| May 29, 2018 | Major Shareholder | 69,444 | $18.00 | Buy | $1,249,992.00 | |
| May 29, 2018 | Insider | 843,352 | $18.97 | Buy | $15,998,387.44 |
Insiders are both buying and selling Kiniksa Pharmaceuticals Ltd stock.
The insider traders at Kiniksa Pharmaceuticals Ltd are: Eben Tessari, Sanj K Patel, Mark Ragosa, John F Paolini, Michael R Megna, Ross Moat, Thomas W Beetham, Thomas Malley, Barry D Quart, James E Flynn, Cormorant Asset Management, Lp, Bros. Advisors Lp Baker, and Barry D. Quart
The most active insider trader at Kiniksa Pharmaceuticals Ltd is Eben Tessari with 18 trades.
Eben Tessari has sold the most Kiniksa Pharmaceuticals Ltd stock with a total value of $16,036,102.36.
Bros. Advisors Lp Baker has bought the most Kiniksa Pharmaceuticals Ltd stock with a total value of $108,000,000.00.
The most recent insider trade for Kiniksa Pharmaceuticals Ltd was on Sept. 15, 2025.
The single biggest insider buy for Kiniksa Pharmaceuticals Ltd was from Bros. Advisors Lp Baker with a total value of $54,000,000.00 on May 29, 2018.
The single biggest insider sell for Kiniksa Pharmaceuticals Ltd was from Eben Tessari with a total value of $4,601,984.80 on Aug. 5, 2025.